The burden of asthma: can it be eased?
Gershon A, Wang C, Cicutto L, To T. Healthc Q. 2007; 10(1):22-4.
Publications
Effect of provider continuity on test repetition
van Walraven C, Cernat G, Austin PC. Clin Chem. 2006; 52(12):2219-28. Epub 2006 Oct 19.
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Paterson JM, Laupacis A, Bassett K, Anderson GM; BC-Ontario Pharmacosurveillance for Decision-Making Collaborative. Health Aff. 2006; 25(5):1436-43.
Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare
Alter DA, Stukel TA, Newman A. Circulation. 2006; 113(3):380-7.
Antipsychotic use in the elderly: shifting trends and increasing costs
Rapoport M, Mamdani M, Shulman KI, Herrmann N, Rochon PA. Int J Geriatr Psychiatry. 2005; 20(8):749-53.
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed
Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. CMAJ. 2005; 172(8):1027-31.
Mechanical ventilation in Ontario, 1992-2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients
Needham DM, Bronskill SE, Sibbald WJ, Pronovost PJ, Laupacis A. Crit Care Med. 2004; 32(7):1504-9.
Differences between systematic reviews and health technology assessments: a trade-off between the ideals of scientific rigor and the realities of policy making
Rotstein D, Laupacis A. Int J Technol Assess Healthcare. 2004; 20(2):177-83.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(12):1359-66.
Using a linked data set to determine the factors associated with utilization and costs of family physician services in Ontario: effects of self-reported chronic conditions
Iron KS, Manuel DG, Williams J. Chronic Dis Can. 2003; 24(4):124-32.